https://onedaytrading.net/bio-news/058edb0a-fa92-4eac-8b23-27b18a7e1ac7 2026-07-04T03:26:56.138Z daily 0.8 원데이트레이딩 ko 2026-07-04T03:26:56.138Z 셀트리온제약 2조 베팅, 시린지 3.5배 증설이 노리는 진짜 자리 https://onedaytrading.net/bio-news/c89350c6-90e5-4dd1-b968-a7643a3c274c 2026-07-03T03:28:08.377Z daily 0.8 원데이트레이딩 ko 2026-07-03T03:28:08.377Z 앱클론 네스페셀 임상 2상 환자모집 완료, 데이터는 아직 없다 https://onedaytrading.net/bio-news/1deca195-1ca6-4e18-a812-7e769f1203f6 2026-07-03T03:26:33.985Z daily 0.8 원데이트레이딩 ko 2026-07-03T03:26:33.985Z 대웅제약 나보타 누적매출 1조 임박, 성장 열쇠는 에볼루스 손에 있다 https://onedaytrading.net/bio-news/ae25e18b-9416-4c3e-9490-e81aba3f0580 2026-07-02T21:29:02.366Z daily 0.8 원데이트레이딩 ko 2026-07-02T21:29:02.366Z 클래리트로마이신 니트로사민 기준 삭제…식약처가 인정한 건 완화 아닌 비변이원성 https://onedaytrading.net/bio-news/9df0dc6a-a375-489a-800a-fb8de4e5c82f 2026-07-02T21:26:31.426Z daily 0.8 원데이트레이딩 ko 2026-07-02T21:26:31.426Z 적응증 5개 신약, 가격도 5개로 나눈다... 건보 급여 새 룰 온다 https://onedaytrading.net/bio-news/19ee5e2e-786e-4510-9a0a-5a71b8563681 2026-07-02T15:27:58.806Z daily 0.8 원데이트레이딩 ko 2026-07-02T15:27:58.806Z 온코소프트 160억 유치, 입자치료 치료계획 SW 외산 독점에 도전장 https://onedaytrading.net/bio-news/1ac0162b-ab81-4c69-bd01-a32784e3ced5 2026-07-02T15:26:15.465Z daily 0.8 원데이트레이딩 ko 2026-07-02T15:26:15.465Z 임종훈, 한미사이언스 지분 반토막낸다… 820억 장외매각의 속내 https://onedaytrading.net/bio-news/5c6fca1a-f3b8-4d39-94eb-58864f3f6edf 2026-07-02T09:30:47.197Z daily 0.8 https://onedaytrading.net/bio-news/fac0f1c3-29e4-4b12-96ca-72db0fabf120 2026-07-02T09:27:52.245Z daily 0.8 https://onedaytrading.net/bio-news/a3d509ca-79c6-44d2-8489-601bb34e00ea 2026-07-02T03:32:56.384Z daily 0.8 https://onedaytrading.net/bio-news/db68a1d1-911f-418c-98c6-12b89c228de6 2026-07-02T03:29:46.206Z daily 0.8